A low ratio of high molecular weight adiponectin to total adiponectin associates with periodontal status in middle-aged men

References

• Ainamo J, Barmes D, Beagrie G, Cutress T, Martin J, Sardo-Infirri J (1982) Development of the World Health Organization (WHO) community periodontal index of treatment needs (CPITN). Int Dent J, 32, 281–91.
   PubMed Web of Science ®Google Scholar
• Almas K, Bulman JS & Newman HN (1991) Assessment of periodontal status with CPITN and conventional periodontal indices. J Clin Periodontol, 18, 654–9.
   Web of Science ®Google Scholar
• Angeli F, Verdecchia P, Pellegrino C, Pellegrino RG, Pellegrino G, Prosciutti L, Giannoni C, Cianetti S & Bentivoglio M (2003) Association between periodontal disease and left ventricle mass in essential hypertension. Hypertension, 41, 488–92.
   PubMed Web of Science ®Google Scholar
• Baelum V, Manji F, Wanzala P & Fejerskov O (1995) Relationship between CPITN and periodontal attachment loss findings in an adult population. J Clin Periodontol, 22, 146–52.
   PubMedGoogle Scholar
• Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M & Fogelman AM (2004) Antiinflammatory properties of HDL. Circ Res, 95, 764–72.
   PubMed Web of Science ®Google Scholar
• Beck JD, Eke P, Heiss G, Madianos P, Couper D, Lin D, Moss K, Elter J & Offenbacher S (2005) Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation, 112, 19–24.
   PubMed Web of Science ®Google Scholar
• Bondy SJ, Victor JC & Diemert LM (2009) Origin and use of the 100 cigarette criterion in tobacco surveys. Tob Control, 18, 317–23.
   PubMed Web of Science ®Google Scholar
• Buhlin K, Hultin M, Norderyd O, Persson L, Pockley AG, Pussinen PJ, Rabe P, Klinge B & Gustafsson A (2009) Periodontal treatment influences risk markers for atherosclerosis in patients with severe periodontitis. Atherosclerosis, 206, 518–22.
   PubMed Web of Science ®Google Scholar
• Bullon P, Morillo JM, Ramirez-Tortosa MC, Quiles JL, Newman HN & Battino M (2009) Metabolic syndrome and periodontitis: is oxidative stress a common link? J Dent Res, 88, 503–18.
   PubMed Web of Science ®Google Scholar
• Dietrich T, Jimenez M, Krall Kaye EA, Vokonas PS & Garcia RI (2008) Age-dependent associations between chronic periodontitis/edentulism and risk of coronary heart disease. Circulation, 117, 1668–74.
   PubMed Web of Science ®Google Scholar
• Ebinuma H, Miyazaki O, Yago H, Hara K, Yamauchi T & Kadowaki T (2006) A novel ELISA system for selective measurement of human adiponectin multimers by using proteases. Clin Chim Acta, 372, 47–53.
   PubMed Web of Science ®Google Scholar
• Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, Offenbacher S, Ridker PM, Van Dyke TE & Roberts WC (2009) The American Journal of Cardiology and Journal of Periodontology Editors’ Consensus: periodontitis and atherosclerotic cardiovascular disease. Am J Cardiol, 104, 59–68.
   PubMed Web of Science ®Google Scholar
• Fujimatsu D, Kotooka N, Inoue T, Nishiyama M & Node K (2009) Association between high molecular weight adiponectin levels and metabolic parameters. J Atheroscler Thromb, 16, 553–9.
   PubMedGoogle Scholar
• Furugen R, Hayashida H, Yamaguchi N, Yoshihara A, Ogawa H, Miyazaki H & Saito T (2008) The relationship between periodontal condition and serum levels of resistin and adiponectin in elderly Japanese. J Periodontal Res, 43, 556–62.
   Google Scholar
• Hansson GK (2005) Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 352, 1685–95.
   PubMed Web of Science ®Google Scholar
• Husten CG (2009) How should we define light or intermittent smoking? Does it matter? Nicotine Tob Res, 11, 111–21.
   PubMed Web of Science ®Google Scholar
• Katz J, Flugelman MY, Goldberg A & Heft M (2002) Association between periodontal pockets and elevated cholesterol and low density lipoprotein cholesterol levels. J Periodontol, 73, 494–500.
   PubMed Web of Science ®Google Scholar
• Komura N, Kihara S, Sonoda M, Kumada M, Fujita K, Hiuge A, Okada T, Nakagawa Y, Tamba S, Kuroda Y, Hayashi N, Sumitsuji S, Kawamoto T, Matsumoto S, Ouchi N, Arita Y, Okamoto Y, Shimomura I, Funahashi T & Matsuzawa Y (2008) Clinical significance of high-molecular weight form of adiponectin in male patients with coronary artery disease. Circ J, 72, 23–8.
   Google Scholar
• Liang KW, Lee WJ, Lee WL, Ting CT & Sheu WH (2009) Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis. Clin Chim Acta, 405, 114–8.
   PubMedGoogle Scholar
• Loe H (1993) Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care, 16, 329–34.
   PubMed Web of Science ®Google Scholar
• Nishida M, Funahashi T & Shimomura I (2007) Pathophysiological significance of adiponectin. Med Mol Morphol, 40, 55–67.
   PubMed Web of Science ®Google Scholar
• Oral health surveys: basic methods, (1997) Geneva, World Health Organization.
   Google Scholar
• Ouchi N & Walsh K (2007) Adiponectin as an anti-inflammatory factor. Clin Chim Acta, 380, 24–30.
   PubMed Web of Science ®Google Scholar
• Page RC & Beck JD (1997) Risk assessment for periodontal diseases. Int Dent J, 47, 61–87.
   PubMedGoogle Scholar
• Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA & Scherer PE (2004) Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. J Biol Chem, 279, 12152–62.
   PubMed Web of Science ®Google Scholar
• Petersen PE, Bourgeois D, Ogawa H, Estupinan-Day S & Ndiaye C (2005) The global burden of oral diseases and risks to oral health. Bull World Health Organ, 83, 661–9.
   PubMed Web of Science ®Google Scholar
• Pihlstrom BL, Michalowicz BS & Johnson NW (2005) Periodontal diseases. Lancet, 366, 1809–20.
   PubMed Web of Science ®Google Scholar
• Pussinen PJ, Jauhiainen M, Vilkuna-Rautiainen T, Sundvall J, Vesanen M, Mattila K, Palosuo T, Alfthan G & Asikainen S (2004) Periodontitis decreases the antiatherogenic potency of high density lipoprotein. J Lipid Res, 45, 139–47.
   PubMed Web of Science ®Google Scholar
• Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, Nagai M, Matsuzawa Y & Funahashi T (2004) Adiponectin as a biomarker of the metabolic syndrome. Circ J, 68, 975–81.
   PubMed Web of Science ®Google Scholar
• Saito T, Shimazaki Y & Sakamoto M (1998) Obesity and periodontitis. N Engl J Med, 339, 482–3.
   PubMed Web of Science ®Google Scholar
• Saito T, Yamaguchi N, Shimazaki Y, Hayashida H, Yonemoto K, Doi Y, Kiyohara Y, Iida M & Yamashita Y (2008) Serum levels of resistin and adiponectin in women with periodontitis: the Hisayama study. J Dent Res, 87, 319–22.
   Google Scholar
• Satoh H, Fujii S & Tsutsui H (2010) The high-molecular weight (HMW) form of adiponectin is a significant surrogate marker for the prediction of type 2 diabetes mellitus in the Japanese population. Nutr Metab Cardiovasc Dis, 20, e9–10
   Google Scholar
• Seino Y, Hirose H, Saito I & Itoh H (2009) High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: a population-based 6-year follow-up study in Japanese men. Metabolism, 58, 355–60.
   PubMed Web of Science ®Google Scholar
• Taylor GW & Borgnakke WS (2008) Periodontal disease: associations with diabetes, glycemic control and complications. Oral Dis, 14, 191–203.
   PubMed Web of Science ®Google Scholar
• Tonetti MS, D’Aiuto F, Nibali L, Donald A, Storry C, Parkar M, Suvan J, Hingorani AD, Vallance P & Deanfield J (2007) Treatment of periodontitis and endothelial function. N Engl J Med, 356, 911–20.
   PubMed Web of Science ®Google Scholar
• von Eynatten M, Humpert PM, Bluemm A, Lepper PM, Hamann A, Allolio B, Nawroth PP, Bierhaus A & Dugi KA (2008) High-molecular weight adiponectin is independently associated with the extent of coronary artery disease in men. Atherosclerosis, 199, 123–8.
   PubMedGoogle Scholar
• Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA & Chen H (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest, 112, 1821–30.
   PubMed Web of Science ®Google Scholar